Skip to main content
Equibles
PETS logo

PETS · Petmed Express Inc

Track PETS — free

Use PETS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.84 -0.06 (-2.91%)
Rebalance outlook locked
Market Cap
$40.76M
Shares
21.68M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.89 Open$1.88 Day$1.87–1.92 52W close$1.60–3.90 Avg vol 30d103K Short int577K · 2.7% float · 5.2d Short vol32% Last earningsAug 13, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Dec 2, 2026 Est · unconfirmed · in 13 wks
FQ2-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.70
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −20%
below
Price vs 50-day avg −1%
below
RSI (14) 52
neutral
MACD trend Positive
52-week position 13%
near low
Momentum
relative strength
Very Weak
1-month return −5%
trailing
6-month return −26%
trailing
YTD return −41%
this year
Relative strength −39%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +9 funds added
Insider flow Accumulating
Net +$43.7K over 90 days · 0% sells
Short interest Falling
2.66% of float · ▼ -12.3% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
50 holders — near 3-yr low, contrarian setup
Squeeze score 61
elevated · 0–100
Fundamentals
Weak
Revenue growth +10%
Y/Y
Gross margin 18%
contracting
EPS growth −813%
Y/Y
Free cash flow $-33.0M
Buyback $28.7M
remaining
Quant / Vol
risk profile
Very High
Volatility 97%
annualized · 1-yr
Max drawdown −57%
past year
ATR 3.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−20% Bearish
Price vs 50-day avg
−1% Neutral
RSI (14)
52 Neutral
MACD trend
Positive Bullish
52-week position
13% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +9 funds added
Insider flow Accumulating
Net +$43.7K over 90 days · 0% sells
Short interest Falling
2.66% of float · ▼ -12.3% MoM · 5.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
50 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $2 Now $2 · 13% Range high $4
vs 200-day avg -20% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Pharmaceutical Retailers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PETS
Petmed Express Inc
this stock
$40.76M -40.9% +9.9% — 2.7%
RTEZ
REST EZ Inc.
 $4.20B — -100.0% — 0.0%
HITI
High Tide Inc.
 $220.55M -5.3% — — 0.7%
SHFH
Scientist Home Future Health Ltd
 $189.73M — — — —
BHIC
BioScience Health Innovations, Inc.
 $53.47M — +208.3% — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
50
% held
21.4%
Net QoQ
-1.4M sh
Top holder
RENAISSANCE TECHNOLOGIES…
Held Float
View
Held by Funds
Fund positions
45
View
Short & Settlement
Short Interest Falling
Shares short
576.6K
Days to cover
5.2d
Change
-80.8K sh
View
Short Volume
Short vol %
32%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
5
Value
$10
As of
Aug 10, 2026
View
Off-Exchange
Off-exchange %
47.5%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$43.7K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$179.0M
Net income (FY)
$-57.3M
EPS diluted
$-2.74
View
Buybacks
Authorized
$110.0M
Remaining
$28.7M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 13, 2026
This year
11
View
Earnings & Events
Earnings Calls
Last call
Aug 13, 2026
View
Investor Relations
Latest news
PetMeds® Announces First Quarter…
Published
Aug 13, 2026
View

Performance

5D 20D 120D MTD YTD
PETS +8.0% -4.6% -26.2% -3.1% -40.9%
SPY +0.5% +1.2% +13.3% +2.7% +12.5%
vs SPY +7.5% -5.8% -39.4% -5.8% -53.4%

Capital returns

Latest dividend
$0.30 / share · ex Aug 11, 2023
Raised 7.1%
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback program · as of Dec 31, 2023
Authorized
$110.00M
Spent (derived)
$81.30M
Remaining
$28.70M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1040130 CUSIP 716382106 13F (30d) 60 filings 47 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)